Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full acquisition. Read on for our thoughts on this and other updates here.
Fusion Antibodies: results underwhelm
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Advanced Medical Solutions
Healthcare advances | Quality in video gaming
News covered here includes our assessment of results from a company operating in the healthcare sector.…
Odd name but great results | Director buying | Retailer woes
News covered here includes our assessment of excellent results from a provider of a diverse range…
More on Argentex Group PLC
Bonkers Bargains: going to plan
A new management team is executing its plan to accelerate growth, making a number of significant new…
Episode 4 of the Investor’s Champion Podcast
In this episode of the Investor’s Champion Podcast, Chris and Lee run through key news from…
More on Frasers Group
AIM takeovers | Automotive excellence and struggles
One of AIM’s largest companies seems inclined to accept a private equity funded offer, with an…
Has Nike been caught flat-footed?
Our portfolio company covered here dominates the market for athletic footwear, but is it the best…
More on Fusion Antibodies PLC
Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…
Coronavirus impact: 28 April - soaring share prices from this little lot
Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…
